Conflict of Interest Statements for The American Journal of Clinical Nutrition Editors

Similar documents
SMA Europe Code of Practice on Relationships with the Pharmaceutical Industry

September 18, 2017 Special Called Meeting of the U. T. System Board of Regents - Meeting of the Board

Purpose of the summary

Yevo Scientific Advisory Board

Managing Conflict of Interest

Biotech Concerto #6 Investment Process December 2008

Other appointments: Chairman of the Advisory Committee of Zentiva Group, Industrial Advisor EQT.

Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy)

Policy for CCG Engagement with the Pharmaceutical Industry

Form FI. Management s Discussion and Analysis of Results of Operations and Financial condition for the six months ended April 30, 2007.

Commercialization Workshop Series Commercialization Pathways. April 2, 2015

Diagnostic assays based on molecular markers Discussion platform on patenting procedures - exchange with NPOs

Patent Purchase Information of Seller

Merriann M. Panarella, Esq. Panarella Dispute Resolution Services P.O. Box Wellesley, MA

Breakfast briefing: Ross DeVol Chief Research Officer Milken Institute September 22, 2011 The Phoenix Park Hotel Washington, DC

Study overview. The Global Biomedical Industry: Preserving U.S. Leadership

Guidelines for Facilitating the Use of Research Tool Patents in the Life Sciences. March 1, 2007 Council for Science and Technology Policy

EL PASO COMMUNITY COLLEGE PROCEDURE

Compliance for Eucomed: The Medical Technology Industry s s Perspective

VTIP in 20 Minutes What You Need to Know

Smith A. Brownlie III, CPA

Key issues in building a strong life sciences patent portfolio. Tom Harding and Jane Wainwright Potter Clarkson LLP

Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond

State of Licensing 2011 Update

PROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium

PATENT AND LICENSING POLICY SUMMARY

CeQur establishes Wales subsidiary

ALAN G. HEVESI, : Defendant. : DEPUTY CHIEF INVESTIGATOR GREGORY J. STASIUK of the Office of

INTELLECTUAL PROPERTY POLICY

TECHNOLOGY TRANSFER AT THE UNIVERSITY OF TENNESSEE: INVENTIONS AND COMMERCIALIZATION

Public Art Network Best Practice Goals and Guidelines

IP and Technology Management for Universities

Connecting People, Science and Regulation

Baxter 2007 Investor Conference March 14, 2007

Committee Member Employment Consultant Speaker s Bureau Ownership/ Partnership / Principal. Expert Witness

Discovery: From Concept to the Patient - The Business of Medical Discovery. Todd Sherer, Ph.D.

Celebrating International Women's Day Friday, March 8, :30am-1:00pm

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum

Achievements of FP7 examples that make us proud

Bayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division

Financing Growth Ventures to Minimize Equity Dilution

Smith A. Brownlie III, CPA

Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA

Life Sciences Queensland announces latest LSQ Ambassadors

Finn Børlum Kristensen, MD, PhD Director, EUnetHTA Secretariat Danish Health and Medicines Authority (EUnetHTA Coordinator) Copenhagen, Denmark

THE BUSINESS OF THE BRAIN 2.0 ACCELERATING PROGRESS TOWARD CURES

Issues in Emerging Health Technologies Bulletin Process

Jean W. Frydman Partner

Richard J. Donoghue Senior Vice President for Strategy, Planning and Business Development

DRAFT. Cardiac Safety Research Consortium CSRC. Membership Committee Charter. 12September2018. Table of Contents

LIGAND PHARMACEUTICALS INCORPORATED (Exact Name of Registrant as Specified in Its Charter)

Authors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade. Digital Patient Engagement. Insights for the Pharmaceutical Industry

Management to Host Conference Call at 8:30 a.m. ET today

Clarke B. Nelson, CPA, ABV, CFF, CGMA, MBA Senior Managing Director & Founder InFact Experts LLC

Teresa V. Pahl Partner

Martha M. Kendrick. Areas of Experience. Practice & Background

Ophthalmic Business Council Connecting Academy and industry leaders for more than 20 years

Intellectual Property

First Course Lobster Bisque Soup with Roasted Fennel. Bread Service Caramelized Onion Walnut Roll with Whipped Maple Brie

Patented Medicine Prices Review Board P M P R B GUIDELINES REFORM. 15 th Annual Market Access Summit. Douglas Clark Executive Director PMPRB

The Global Alliance for Chronic diseases (GACD)

Food Science for the Non-Food Scientist Instructor Biographies

California State University, Northridge Policy Statement on Inventions and Patents

INTERNATIONAL WINTER SCHOOL

Science - Industry Relationships in High-tech Sectors: Transatlantic Perspectives

Virtual Clinical Trials: Challenges and Opportunities

PATENTS FOR CHEMICALS, PHARMACEUTICALS AND BIOTECHNOLOGY

Additional information about Christopher Wootton is available on the SEC s Web site at

Keynote speakers 2017

Report OIE Animal Welfare Global Forum Supporting implementation of OIE Standards Paris, France, March 2018

We Work For Health Champions Awards Class of AstraZeneca: John McCarthy Vice President, Commercial Operations

Industrial Investment in Research and Development: Trends and Prospects

EU Livestock subsidies' effect on red meat consumption

To the shareholders of Nordic Nanovector ASA Oslo, 8 May 2018

Academic Technology Licensing & the America Invents Act

Second medical use claims The pregabalin litigation in Europe IMK seminar at Awapatent, 18 May 2017

LISA ROTH MONAHAN & ROTH, LLC 630 FIRST AVENUE SAN DIEGO, CA 92101

Loyola University Maryland Provisional Policies and Procedures for Intellectual Property, Copyrights, and Patents

2008 HSC Notes from the Marking Centre Food Technology

Shareholders are invited to the 2018 Annual Meeting which is scheduled for 27 September 2018.

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)

2016 ICGN Annual General Meeting

How To Draft Patents For Future Portfolio Growth

Size of California s economy US$ trillions, 2009

South-South Exchange Meeting on the Conservation and Sustainable Use of Forest Biodiversity, 8-10 July 2009

Sofosbuvir Patent Oppositions at European Patent Office

HTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as:

150th Annual General Meeting of Nestlé S.A. Lausanne, 6 April Speeches. Peter Brabeck-Letmathe Chairman of the Board

PROMETIC REPORTS 2017 THIRD QUARTER HIGHLIGHTS AND FINANCIAL RESULTS

The 2011 EU industrial R&D investment SCOREBOARD

WIPO NATIONAL WORKSHOP FOR PATENT LAWYERS

Eligibility Criteria Created Sunday, November 09, 2014

INTELLECTUAL PROPERTY OVERVIEW. Patrícia Lima

Meeting of the EDEN HEALTH DISTRICT BOARD OF DIRECTORS OPEN SESSION January 16, 2019 Eden Health District - Conference Room. 5:30 p.m.

[Definitions of terms that are underlined are found at the end of this document.]

Transferring UCLA discoveries to the public. Kathryn Atchison, DDS, MPH Vice Provost, Associate Vice Chancellor for Research

THE EUROPEAN COUNCIL OF ACADEMIES OF APPLIED SCIENCES, TECHNOLOGIES AND ENGINEERING

Implementation of Systems Medicine across Europe

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

SPONSORED BY WORLD GOLD TRUST SERVICES, LLC

Transcription:

Conflict of Interest Statements for The American Journal of Clinical Nutrition Editors David B Allison Dr. Allison has received personal payments or promises for same from: American Society for Nutrition; Biofortis; Frontiers Publishing; IKEA; Indiana University; Laura and John Arnold Foundation; Law Offices of Ronald Marron; MD Anderson Cancer Center; National Academy of Sciences; National Institutes of Health (NIH); Nestlé; Paul Hastings, LLP; Texas A&M University; The Obesity Society; Tomasik, Kotin & Kasserman LLC; University of Miami. Dr. Allison receives editorial honoraria from the American Society for Nutrition and the Obesity Society. Donations to a foundation have been made on his behalf by the Northarvest Bean Growers Association and the United Soy Bean Board. Dr. Allison is an unpaid member of the International Life Sciences Institute North America Board of Trustees. Dr. Allison s institution, Indiana University, has received funds to support his research or educational activities from: USDA; NIH; US National Science Foundation; Alliance for Potato Research and Education; Dairy Management Institute; Herbalife; Laura and John Arnold Foundation. Arne Astrup Dr. Astrup receives payment as Associate Editor of The American Journal of Clinical Nutrition and as a member of the Editorial Committee of Annual Review of Nutrition. Dr. Astrup is advisor to or a member of advisory boards for a number of food and pharmaceutical producers: Basic Research, United States; Beachbody, United States; BioCare Copenhagen, Denmark; Crossfit, United States; Dutch Beer Institute, Netherlands; Feast Kitchen A/S, Denmark; Gelesis, United States; Groupe Éthique et Santé, France; McCain Foods Limited, United States; Nestlé Research Centre, Switzerland; Novo Nordisk, Denmark; Pfizer, Germany; Saniona, Denmark; Sanofi- Aventis, Germany; S-Biotek, Denmark; Scandinavian Airlines System, Denmark; TetraPak, Sweden; Weight Watchers, United States; Zaluvida, Switzerland. Dr. Astrup does not own stock in, or have other ownership interests in, any of the companies to which he provides scientific advice, or in any nutrition company other than those companies whose stock

is held by various mutual fund retirement accounts. Dr. Astrup s recent research at the University of Copenhagen, Denmark, has received funding via unrestricted grants from or contracts with DC-Ingredients, Denmark; Danish Dairy Foundation; Global Dairy Platform; and Gelesis AS, United States. Dr. Astrup is the recipient of honoraria as speaker for a wide range of Danish and international concerns and receives royalties from textbooks and popular diet and cookery books. Dr. Astrup is co-inventor of a number of patents, including Methods of inducing weight loss, treating obesity and preventing weight gain (licensee Gelesis, United States) and Biomarkers for predicting degree of weight loss (licensee Nestec SA, Switzerland), owned by the University of Copenhagen, in accordance with Danish law. Dr. Astrup is co-founder and co-owner of the University of Copenhagen spin-out companies Mobile Fitness A/S, Personalized Weight Management Research Consortium ApS (Gluco-diet.dk), and Flaxslim ApS, where he is also member of the board. Dr. Astrup is not an advocate or activist for specific diets and is not strongly committed to any specific diet, e.g., veganism, Atkins diet, glutenfree diet, high animal protein diet, or dietary supplements. Dennis M Bier Dr. Bier accepts no honorarium for the work he performs as Editor-in-Chief of The American Journal of Clinical Nutrition. Dr. Bier is an advisor to the International Council on Amino Acid Science, whose members include companies that produce and market amino acids for medical, biological, and industrial purposes. Dr. Bier provides the Council with advice on scientific priorities, assistance in organizing scientific symposia on amino acids, and evaluation of competitive applications for research funding. Other than reimbursement for travel expenses, he accepts no compensation for his advisory role. In the past year, Dr. Bier has consulted for, and received honoraria from, Mallinckrodt Pharmaceuticals; Novartis Pharmaceuticals; Nestlé SA; Ajinomoto Co., Inc.; Soremartec Italia S.r.l.; the CrossFit Foundation; Intertek Scientific and Regulatory Consultancy Services; Nutritional Growth Solutions; the Dairy Management Institute;

and the Lorenzini Foundation. The majority of Dr. Bier s consulting fees are donated to charity. Dr. Bier does not own stock in, or have other ownership interests in, any of the companies to which he provides scientific advice or in any nutrition company other than those companies whose stock is held by various mutual fund retirement accounts. Paul M Coates Dr. Coates does not receive an honorarium from the American Society for Nutrition for his duties as Associate Editor. Naomi K Fukagawa Dr. Fukagawa receives an honorarium from the American Society for Nutrition for her duties as Associate Editor. Dr. Fukagawa serves as Director of the USDA Beltsville Human Nutrition Center. Dr. Fukagawa is the Editor-in-Chief of Nutrition Reviews. David M Klurfeld Dr. Klurfeld does not receive an honorarium from the American Society for Nutrition for his duties as Associate Editor. Dr. Klurfeld is a nutrition consultant to Dyets, Inc, a manufacturer of diets for laboratory animals. Dr. Klurfeld is a member of the American Council on Science and Health Board of Scientific and Policy Advisors whose function is to provide advice and review of statements developed by the organization. This is a noncompensated position. Simin Liu Dr. Liu reports consulting payments and honoraria or promises of the same for scientific presentations or reviews at numerous venues, including but not limited to Barilla, Johns Hopkins University, Fred Hutchinson Cancer Center, Harvard University, University of Buffalo, GuangDong General Hospital and Academy of Medical Sciences, and the National Institutes of Health. He is also a member of the Data Safety and Monitoring Board for a trial of pulmonary hypertension in diabetes patients at Massachusetts General Hospital. He receives royalties from UpToDate. Dr.

Liu receives an honorarium from the American Society for Nutrition for his duties as Associate Editor. Dr. Liu is listed as the lead inventor on U.S. Application Serial No. or PCT International Application No. PCT/US2009/064656 filed on November 16, 2009 by UCLA concerning METHODS AND COMPOSITIONS FOR PREDICTING A SUBJECT'S SUSCEPTIBILITY TO AND RISK OF DEVELOPING TYPE 2 DIABETES. Mark J Manary Dr. Manary is the Director of Project Peanut Butter, a not-for-profit focusing on improving the treatment of malnutrition as well as the production of appropriate, nutrient-dense foods. His present research activities are funded primarily by Children s Investment Fund Foundation and USAID Feed the Future program. Dr. Manary has accepted contributions of food ingredients necessary for his research work from Arla Dairy Ingredients. Dr. Manary has provided technical advice in areas of his competence on an ad-hoc basis. He does not own personal stock except for investment funds related to his pension that are not under his direct control. Dr. Manary is a member of the WHO technical expert committee on nutrition, which reviews evidence and writes draft guidelines for treatment and prevention of malnutrition worldwide. Dr. Manary does not hold or have pending patent applications related or unrelated to his research activities. Dr. Manary has spoken at meetings and conferences at the invitation of organizations representing the peanut and dairy industries, usually once a year; they have paid his travel expenses, but he has not accepted personal payments or honoraria from these organizations. Dr. Manary receives an honorarium from the American Society for Nutrition for his duties as Associate Editor. Richard Mattes Dr. Mattes receives an honorarium from the American Society for Nutrition for his duties as Associate Editor. Dr. Mattes has received travel expenses and/or honoraria for serving on scientific advisory bodies forconagra and the Grain Food Foundation and planning committees for the American Society for Nutrition, Academy for Nutrition and Dietetics, and Institute for Food Technologists. Dr. Mattes has received

research support and/or travel expenses from the Almond Board of California, California Walnut Commission, and Ajinomoto Co. Inc. Dr. Mattes has received travel expenses and/or honoraria for speaking at various professional meetings. Sue A Shapses Dr. Shapses receives an honorarium from the American Society for Nutrition for her duties as Associate Editor; the honorarium is used for scholarship and research purposes. Dr. Shapses, as an investigator, received research funds or consulting fees from Merck, Inc., Omni Active Tech., and Bayer, Inc. Dr. Shapses received honorarium fees and/or travel reimbursement from Johns Hopkins University, Columbia University, Wake Forest School of Medicine, and the American College of Sports Medicine. Dr. Shapses receives honorarium fees and/or travel reimbursement for consulting duties at NASA and NIH.